QUBIS joined seven portfolio companies in Boston for a programme of industry engagement and networking, culminating in the MassBio Align Summit, where two portfolio companies were selected to pitch to an international audience.
QUBIS recently led a delegation of seven portfolio companies to Boston, one of the world's leading life sciences hubs, to strengthen transatlantic connections and explore new opportunities for growth and collaboration.
The delegation included AMPLY Discovery, CV6 Therapeutics, Respiratory Analytics, Re-Vana Therapeutics, SignaCor, StimOxyGen and VacTimmune, representing a diverse range of innovations across the life sciences and healthcare sectors.
The visit combined industry engagement, knowledge sharing and networking opportunities, culminating in attendance at the 2026 MassBio Align Summit, which QUBIS was proud to sponsor.
Showcasing Innovation at MassBio Align
The MassBio Align Summit brings together emerging biotechnology companies, investors, pharmaceutical leaders and industry experts to foster connections and accelerate innovation across the life sciences sector.
A key highlight for the QUBIS delegation was the selection of two portfolio companies to pitch at the conference.
Darach Neeson of SignaCor and Dermot Tierney of AMPLY Discovery were selected to present their companies to an international audience, providing an opportunity to showcase their innovations and engage with potential investors, collaborators and strategic partners.
The summit also provided a platform for the wider QUBIS delegation to connect with key stakeholders in the US life sciences ecosystem and explore opportunities to support their future development.
QUBIS's sponsorship of the event reflects its commitment to supporting early-stage innovation and strengthening international relationships that can help portfolio companies scale.
Building Transatlantic Partnerships
Ahead of the conference, the delegation participated in a workshop hosted by international law firm Jones Day, providing insights into the US business environment and opportunities for international expansion.
Representatives from the Boston Irish Business Association also contributed to the session, sharing perspectives on building commercial relationships and establishing a presence in the region.
The programme enabled participating companies to gain valuable market insights, connect with experienced industry professionals and develop relationships within Boston's established innovation ecosystem.
Supporting International Growth
Boston remains a key global centre for biotechnology, attracting leading research institutions, pharmaceutical companies, investors and emerging innovators.
QUBIS's participation in the MassBio Align Summit forms part of its ongoing commitment to helping Queen's University Belfast spinout companies access international networks, investment opportunities and strategic partnerships.
Building on the connections established during the visit, QUBIS will continue to explore opportunities for collaboration with MassBio and the wider US life sciences community, supporting its portfolio companies as they progress their technologies and pursue international growth.
For more information, visit the MassBio Align Summit.